# Ari David Baron

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ari-david-baron/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,910 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 35 |
| i10-index | 58 |
| Last Known Institution | California Pacific Medical Center |
| OpenAlex ID | https://openalex.org/A5007159753 |
| ORCID iD | https://orcid.org/0000-0003-1247-3094 |
| Works | 109 |

## Researcher papers

- [Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial](https://scholariq.org/papers/ramucirumab-versus-placebo-as-second-line-treatment-in-patients-with-advanced/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

## Researcher university

- [California Pacific Medical Center](https://scholariq.org/institutions/california-pacific-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.